InvestSMART

Enlitic Inc (ASX:ENL)

ALERT: Price-sensitive ASX Announcement for ENL
Current share price for ENL : $0.005 -0.001 (-16.67%)+
Announcement
Release
23 Mar 2026 8:21AM
Price at Release
$0.006
Full Release
download
Summary
Enlitic Inc has entered a US$1.5 million data migration contract with Penn Medicine Doylestown Health. The project involves migrating over 71 million legacy clinical files into a modernized archive within Enlitic's platform, facilitated by its subsidiary Laitek. This initiative is expected to begin in Q2 2026 and emphasizes Enlitic's ongoing partnership with Penn Medicine, as well as its proficiency in handling complex data migration projects. The company also plans to leverage this opportunity to expand its solution offerings with Penn Medicine.
Key Points
  • Enlitic Inc signed a US$1.5 million data migration contract with Penn Medicine Doylestown Health.
  • Laitek, Enlitic's medical imaging data migration company, will migrate over 71 million legacy clinical files.
  • The migration will modernize the archive structure within Enlitic's platform using a bespoke solution.
  • The project showcases Enlitic's ongoing relationship with Penn Medicine and demonstrates the value of their offering.
  • The data migration project is expected to commence in Q2 2026 and complete within the same calendar year.
  • Enlitic aims to expand its relationship by implementing additional solutions with Penn Medicine.
  • This project highlights Enlitic's expertise in managing complex clinical data migration and transformation projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.